Nanobody-Based high-performance immunosorbent for selective beta 2-microglobulin purification from blood
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 107, 232-241
Abstract
No abstract availableKeywords
Funding Information
- Central Universities (DUT19LAB31)
- Dalian Key Technology R&D Program (2018YF22SN062)
- Dalian Innovation Support Plan for High Level Talents (2016RQ023)
This publication has 45 references indexed in Scilit:
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- Survey of the Effects of a Column for Adsorption of β2‐Microglobulin in Patients With Dialysis‐Related Amyloidosis in JapanTherapeutic Apheresis and Dialysis, 2012
- In Vitro Removal of Beta‐2‐Microglobulin From Uremic Blood With an Immunoadsorption WallArtificial Organs, 2011
- Clearance of p-Cresol Sulfate and β-2-Microglobulin from Dialysate by Commercially Available Sorbent TechnologyASAIO Journal, 2011
- Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltrationKidney International, 2006
- Assessment of the Stability of an Immunoadsorbent for the Extracorporeal Removal of Beta-2-Microglobulin from BloodBlood Purification, 2005
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003
- High permeability of dialysis membranes: what is the limit of albumin loss?Nephrology Dialysis Transplantation, 2003
- Immunoadsorption model for a novel fluidized‐bed blood detoxification deviceAIChE Journal, 2002
- A novel immunoadsorption device for removing β2-microglobulin from whole bloodKidney International, 2001